Article

Radiolabelling: Seeing Through The Mist

Is the parent drug as well as its associated metabolites adequately evaluated for safety in preclinical studies?
Dr Sean Kitson from Almac’s Radiolabelling and Biocatalysis Group gives an interpretation.

View Resource

Please complete this form to view the Article

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies